AU Patent

AU2016313439B2 — Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same

Assigned to Pfizer Inc · Expires 2019-10-03 · 7y expired

What this patent protects

The present disclosure generally relates to nanoparticles comprising an endo-lysosomal escape agent, a nucleic acid, and a polymer. Other aspects include methods of making and using such nanoparticles.

USPTO Abstract

The present disclosure generally relates to nanoparticles comprising an endo-lysosomal escape agent, a nucleic acid, and a polymer. Other aspects include methods of making and using such nanoparticles.

Drugs covered by this patent

Patent Metadata

Patent number
AU2016313439B2
Jurisdiction
AU
Classification
—
Expires
2019-10-03
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.